Day One Biopharmaceuticals, Inc. (DAWN): Price and Financial Metrics

Day One Biopharmaceuticals, Inc. (DAWN): $13.62

0.10 (+0.74%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add DAWN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#62 of 332

in industry

DAWN Price/Volume Stats

Current price $13.62 52-week high $18.07
Prev. close $13.52 52-week low $11.30
Day low $13.32 Volume 577,900
Day high $13.71 Avg. volume 959,002
50-day MA $14.37 Dividend yield N/A
200-day MA $14.63 Market Cap 1.37B

DAWN Stock Price Chart Interactive Chart >


Day One Biopharmaceuticals, Inc. (DAWN) Company Bio


Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.


DAWN Latest News Stream


Event/Time News Detail
Loading, please wait...

DAWN Latest Social Stream


Loading social stream, please wait...

View Full DAWN Social Stream

DAWN Price Returns

1-mo -5.81%
3-mo -3.34%
6-mo -1.09%
1-year 14.74%
3-year -28.43%
5-year N/A
YTD -6.71%
2023 -32.16%
2022 27.72%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!